Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 559

Results For "NAL"

6624 News Found

Cipla’s Q3FY22 PAT at Rs 729 cr.
News | January 26, 2022

Cipla’s Q3FY22 PAT at Rs 729 cr.

Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.


Mandaviya reviews public health preparedness to Covid-19
Policy | January 26, 2022

Mandaviya reviews public health preparedness to Covid-19

Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation


Quantori names Arun Nayar as Global Head of R&D Informatics
People | January 26, 2022

Quantori names Arun Nayar as Global Head of R&D Informatics

New role strengthens Quantori’s global leadership position in data science & digital IT


Astec LifeSciences Q3FY22 PAT at Rs 24.74 cr.
News | January 26, 2022

Astec LifeSciences Q3FY22 PAT at Rs 24.74 cr.

Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021


Philips introduces at-home, 12-lead ECG integrated solution for trials
Medical Device | January 26, 2022

Philips introduces at-home, 12-lead ECG integrated solution for trials

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials


FDC’s chooses UFlex’ Asepto holographic packaging for Electral
Packaging | January 25, 2022

FDC’s chooses UFlex’ Asepto holographic packaging for Electral

The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid


JSW opens 300-bed covid centre in Karnataka
Public Health | January 25, 2022

JSW opens 300-bed covid centre in Karnataka

The covid health center will be managed and administered by the district administration of Ballari


USFDA rejects Merck’s gefapixant; gain approval in Japan
News | January 25, 2022

USFDA rejects Merck’s gefapixant; gain approval in Japan

Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant


SQI Diagnostics inks pact with UK-Based Owlstone Medical
Biotech | January 25, 2022

SQI Diagnostics inks pact with UK-Based Owlstone Medical

Companies plan to commercialize breath-based detection of lung infection and transplant rejection


Merck donates 1.5 billionth tablet of praziquantel to Africa
Public Health | January 25, 2022

Merck donates 1.5 billionth tablet of praziquantel to Africa

The tablet donations provided for the treatment of more than 600 million schoolchildren in affected countries in sub-Saharan Africa since 2007